...
首页> 外文期刊>Carcinogenesis >Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis.
【24h】

Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis.

机译:胰岛素样生长因子结合蛋白5(IGFBP-5)通过抑制血管生成而充当肿瘤抑制因子。

获取原文
获取原文并翻译 | 示例

摘要

Insulin-like growth factor-binding protein-5 (IGFBP-5) is one of the six members of IGFBP family, important for cell growth control, induction of apoptosis and other IGF-stimulated signaling pathways. In this study, we focused on characterizing the specific function of IGFBP-5 as novel antiangiostatic factor. Overexpression of IGFBP-5 suppressed the tube formation as well as the biological functions of angiostatic activity in vivo. This result is due to the reduced expressions of phosphorylated protein kinase B and phosphorylated endothelial NO synthase, which plays important roles in the regulation of angiogenesis when stimulated by vascular endothelial growth factor. Further, IGFBP-5 expression prevented tumor growth and inhibited tumor vascularity in a xenograft model of human ovarian cancer. These results are the first evidence showing that IGFBP-5 plays a role as tumor suppressor by inhibiting angiogenesis.
机译:胰岛素样生长因子结合蛋白5(IGFBP-5)是IGFBP家族的六个成员之一,对细胞生长控制,细胞凋亡的诱导和其他IGF刺激的信号传导通路都很重要。在这项研究中,我们专注于表征IGFBP-5作为新型抗血管生成因子的特定功能。 IGFBP-5的过表达抑制了管的形成以及体内血管抑制活性的生物学功能。该结果归因于磷酸化蛋白激酶B和磷酸化内皮NO合酶的表达降低,当被血管内皮生长因子刺激时,其在调节血管生成中起重要作用。此外,在人卵巢癌的异种移植模型中,IGFBP-5表达阻止了肿瘤的生长并抑制了肿瘤的血管。这些结果是表明IGFBP-5通过抑制血管生成而起肿瘤抑制作用的第一个证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号